Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Endometrial Cancer

Clinical Trials

    • Cancer(5)
  • Thyroid and Other Endocrine Cancers, Gynecological Cancers

    Endometrium and Metabolism

    • Gynecological Cancers

      A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma

      • Gynecological Cancers

        A Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial Cancer

        • Gynecological Cancers

          Trial of Exercise and Lifestyle (TEAL) for Women with Ovarian and Endometrial Cancer

          • Gynecological Cancers

            A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

            • About Us
            • Contact Us
            • Donate
            • Referring Doctors
            • Clinical Keywords

            333 Cedar St.

            New Haven, CT 06510

            • Yale School of Medicine
            • Yale University
            • Terms & Privacy Policies
            • Accessibility at YSM
            • Patient Rights
            • HIPAA at Yale
            • Non-discrimination Statement
            Copyright 2025 Yale Medicine